Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 620 of 6351
-
Engineered immune cells take on tough blood cancers in early trial
Disease control Recruiting nowThe aim of this study was to evaluate the safety and efficacy of universal CD7 CART (uCD7 CART) cells in the treatment of patients with relapsed/refractory CD7-positive hematologic malignancies. In this single-arm, open-label, single-center, Phase 1 clinical trial, two cohorts we…
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 26, 2026 12:55 UTC
-
Promising drug targets lung cancer brain tumors in early trial
Disease control Recruiting nowREPOSE is a phase II clinical trial exploring the safety and efficacy of repotrectinib in patients with non-small cell lung cancer (NSCLC) characterized by the presence of brain metastasis (BM) and whose tumors have mutated ROS proto-oncogene 1, receptor tyrosine kinase (ROS1) ge…
Phase 2 • Sponsor: MedSIR • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
Stem cell virus therapy takes on deadly brain tumors
Disease control PausedThe goal of this clinical trial is to learn about the safety and feasibility of administering repeated doses of neural stem cell (NSC)-conditionally replicative adenovirus (CRAd)-survivin (S)-protomer (p)k7, in persons with newly diagnosed high grade glioma. The main questions i…
Phase 1 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for HS sufferers: Long-Term drug trial expands
Disease control By invitation onlyThis is a study to evaluate the long-term safety, tolerability, and efficacy of sonelokimab in participants with moderate to severe hidradenitis suppurativa who were previously enrolled in a parental study.
Phase 3 • Sponsor: MoonLake Immunotherapeutics AG • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New drug aims to stop bleeds in rare blood disorder
Disease control Recruiting nowThis is a Phase III, multicenter, open-label clinical study designed to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of emicizumab prophylaxis in participants aged 1 month and above, who have been diagnosed with Type 3 von Willebrand disease (VWD). Partic…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
New pill could fight bladder cancer without surgery
Disease control Recruiting nowPhase 2 Study of TYRA-300 in FGFR3 Altered Low Grade, Intermediate Risk NMIBC
Phase 2 • Sponsor: Tyra Biosciences, Inc • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
New hope for HLH patients: targeted drug tested in clinical trial
Disease control Recruiting nowThis study aims to investigate the efficacy and safety of Golidocitinib(GO) monotherapy in the treatment of hemophagocytic lymphohistiocytosis.
Phase 2/3 • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
AI maps heart's faulty signals to boost AFib treatment
Disease control Recruiting nowThe goal of this clinical trial is to compare the use of the Vektor Computational ECG Mapping System (vMap®) with pulmonary vein isolation (PVI), to using PVI alone, to treat Atrial Fibrillation (AF) in adults. Participants will have a 50/50 or 1 out of 2 chance of being placed …
Sponsor: Vektor Medical • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
AI may match depression patients to the right therapy faster
Disease control Recruiting nowDepression and anxiety are common mental health problems affecting around one in six adults. Treatments include therapy, telephone or group-based activities delivered by therapists. Treatment uses a "stepped care" model where most patients start with very brief treatments. If the…
Sponsor: Rotherham Doncaster and South Humber NHS Foundation Trust • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Can a slower intubation approach prevent dangerous blood pressure drops?
Disease control Recruiting nowThe goal of this clinical trial is to learn if it is feaseble to conduct a superiority trial comparing two methods for endotracheal intubation in critically ill patients. It will also learn about validity of outcomes regarding endotracheal intubation. The main questions it aims t…
Sponsor: Leipzig University Medical Center • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can a Weight-Loss drug boost Crohn's treatment? new trial aims to find out
Disease control Recruiting nowThe main purpose of this study is to evaluate the efficacy and safety of mirikizumab and placebo compared with mirikizumab and concomitantly administered tirzepatide in adult participants with moderately to severely active CD and obesity, or overweight. The maximum duration of t…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New combo therapy targets gut disease and obesity together
Disease control Recruiting nowThe main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with mirikizumab and placebo, leads to decrease or disappearance of UC symptoms, and loss of at least one-tenth of the overall body wei…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New hope for DM1: Long-Term trial of AOC 1001 underway
Disease control By invitation onlyA Global Phase 3 Open-Label Extension Study to Assess the Long-Term Safety, Tolerability, and Efficacy of Intravenous Delpacibart Etedesiran (abbreviated del-desiran, formerly AOC 1001) for the Treatment of Myotonic Dystrophy Type 1
Phase 3 • Sponsor: Avidity Biosciences, Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can an antibody boost help transplant patients beat CMV faster?
Disease control By invitation onlyCytomegalovirus (CMV) is a significant opportunistic pathogen and a major cause of morbidity and mortality in solid organ transplant recipients. CytoGam - Cytomegalovirus Immune Globulin Intravenous (CMV-IGIV), is an immunoglobulin G containing a standardized amount of antibody a…
Phase 4 • Sponsor: Fernanda P Silveira, MD, MS • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
Fewer radiation sessions could boost cervical cancer fight
Disease control Recruiting nowThe goal of this clinical trial is to investigate the use of hypofractionated radiation (delivery of fewer but larger doses of radiation) with concurrent chemotherapy for women with metastatic of bulky uterine cervix cancer. The main questions it aims to answer are: * What is th…
Phase 2 • Sponsor: Denise Fabian • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New hope for IBD sufferers: two experimental drugs enter Mid-Stage trial
Disease control Recruiting nowThis is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.
Phase 2 • Sponsor: Mirador Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Revolutionary ICU trial aims to save lives by constantly learning from every patient
Knowledge-focused Recruiting nowAmong critically ill patients, many die, and many of the survivors and their family members struggle for years with reduced quality of life. Critically ill patients are treated in intensive care units (ICUs). Here, they receive life support, e.g., mechanical ventilation and advan…
Phase 4 • Sponsor: Anders Perner • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Virus therapy takes on Hard-to-Treat lung cancer brain spread
Disease control Recruiting nowPhase Ib/II clinical study on evaluating the safety, tolerance, biodistribution characteristics and preliminary efficacy of recombinant human nsIL12 oncolytic adenovirus injection (BioTT001) in the treatment of meningeal metastasis in recurrent/progressive non-small cell lung can…
Phase 1/2 • Sponsor: Henan Cancer Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Can your own belly fat fix your aching knee?
Disease control OngoingThis randomized, controlled clinical trial will evaluate the safety and effectiveness of autologous adipose-derived stromal vascular fraction (SVF) therapy in patients with knee osteoarthritis (OA) grades II-IV, compared with standard chondroprotective (CP) treatment. The study w…
Phase 4 • Sponsor: Clinical Center of Vojvodina • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New shot could replace pills to prevent clots after knee surgery
Disease control Recruiting nowThis study is researching an experimental drug called REGN7508 (called "study drug"). The study is focused on adults undergoing elective, unilateral (one side) total knee replacement surgery. The aim of the study is to see how effective the study drug is at preventing Venous Thr…
Phase 3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC